Kenjiro Okubo, Toshiyuki Kudo, Sae Yoshihara, Yu Nakabayashi, Kana Nakauchi, Akimi Tanaka, Moe Saito, Ayumi Tsujisawa, Hitomi Goda, Yoshiaki Yamagishi, et al. Physiologically based pharmacokinetic model analysis of the inhibitory effect of vonoprazan on the metabolic activation of proguanil. Drug Metabolism and Pharmacokinetics. 2024. 54. 100537-100537
Tomohisa Nakada, Toshiyuki Kudo, Kiyomi Ito. Quantitative Consideration of Clinical Increases in Serum Creatinine Caused by Renal Transporter Inhibition. Drug metabolism and disposition: the biological fate of chemicals. 2023
Toshiyuki Hikita, Hitomi Goda, Yasuko Ogawa, Toshiyuki Kudo, Kiyomi Ito. Caffeine consumption as a risk factor for childhood and adolescence migraine. Pediatrics international : official journal of the Japan Pediatric Society. 2023. 65. 1. e15429
Kentaro Ohta, Nobuko Matsushima, Hiromi Tanii, Herta Crauwels, Toshiyuki Kudo, Kiyomi Ito. Pharmacokinetics and safety of rilpivirine in healthy Japanese subjects and exploration of ethnic sensitivity of rilpivirine pharmacokinetics with physiologically based pharmacokinetic model approach. Drug metabolism and pharmacokinetics. 2021. 41. 100422-100422
2014/01 - Drug Metabolism Division of ASPET James R. Gillette Drug Metabolism Best Paper of 2013 Analysis of the Repaglinide Concentration Increase Produced by Gemfibrozil and Itraconazole Based on the Inhibition of the Hepatic Uptake Transporter and Metabolic Enzymes